This announcement is a separate document:
中信证券股份有限公司关于北京神州细胞生物技术集团股份公司向控股股东进行永续债权融资暨关联交易事项的核查意见
CITIC Securities Limited's verification opinion on the perpetual debt financing and related party transactions conducted by Beijing Shenzhou Cell Biotechnology Group Co., Ltd. to its controlling shareholders.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated